E

Elpiscience Biopharmaceuticals, Inc.

34 employees

Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Macrophage engaging
Myeloid biology
Pharmaceutical
tumor microenvironment
Biopharma
Immuno-oncology
Immune suppressive factors

Date founded

2017

Funding rounds raised

Total raised

$105M

from 16 investors over 16 rounds

E

Elpiscience Biopharmaceuticals, Inc. raised $105M on May 13, 2021

Investors: Lilly Asia Ventures, 厦门德屹股权投资管理有限公司, 清科集团, -, CDH Investments and Maison Capital

E

Elpiscience Biopharmaceuticals, Inc. raised $100M on December 28, 2019

Investors: 厦门德屹股权投资管理有限公司, Lilly Asia Ventures, 盛山资产管理(上海)有限公司, Hillhouse Capital Management, CDH Investments and Tencent

E

Elpiscience Biopharmaceuticals, Inc. raised $35M on December 3, 2018

Investors: Lilly Asia Ventures, Hillhouse Capital Management and CDH Investments

E

Elpiscience Biopharmaceuticals, Inc. raised $20M on April 3, 2017

Investors: Lilly Asia Ventures

FAQ